Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pak Med Assoc ; 69(3): 367-372, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30890829

RESUMEN

OBJECTIVE: To investigate the role of environmental variation, genetic differences and age on disposition kinetics, renal clearance and urinary excretion of oral cefixime 400mg in healthy boys. METHODS: The cross-sectional study was conducted at the University of Agriculture, Faisalabad, Pakistan, from August 2014 to July 2015, and comprised healthy boys aged 12-17 years after oral administration of cefixime capsule 400mg. Serum and urine samples were collected before and after drug administration and were stored at - 20oC until evaluation of cefixime concentration in each sample by high performance liquid chromatography. Drug concentration versus time data was used for pharmacokinetic calculations using one compartment model. Data obtained for urinary excretion and renal clearance of cefixime was analysed using regression-correlation analysis. RESULTS: There were eight boys in the study. Mean values for elimination half-life, volume of distribution and total body clearance were 2.4}0.2 hours, 0.9}0.0L/kg and 0.3}0.0L/h/kg, respectively. The ratio of renal clearance of cefixime (0.7 ml/min/kg) to that of endogenous creatinine (0.8ml/min/kg) was 0.9. Cumulative mean percentage of cefixime excreted from young adolescent boys was 11.6 } 0.5%. CONCLUSION: Other than filtration, back-diffusion was also involved in renal handling of cefixime. There was enough indication that major portion of cefixime was excreted from a young body through bile.


Asunto(s)
Antibacterianos/farmacocinética , Cefixima/farmacocinética , Adolescente , Antibacterianos/sangre , Antibacterianos/orina , Cefixima/sangre , Cefixima/orina , Niño , Creatinina/metabolismo , Humanos , Masculino , Pakistán , Eliminación Renal
2.
Biomed Chromatogr ; 32(2)2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28833295

RESUMEN

Cefexime is a useful antibiotic that can be prescribed to treat bacterial infections. Nanoparticles have been widely marketed as a universal solution among scientists. Many studies have been performed to modify nanoparticles to make them functional as extraction and pre-concentration agents and drug carriers. Temperature-sensitive polymers belong to a group of substances that undergo a major change in their physical features in response to temperature. Recently developed polymers can be used in many different areas, including modification of nanoparticles. In order to modify this nanoparticle, grafting copolymerization of Fe3 O4 nanoparticles was performed using poly (N-vinylcaprolactam) and 3-allyloxy-1,2-propanediol. The optimum conditions for pre-concentration of cefexime were studied. Under these optimum conditions, extraction recovery of biological samples in the range of 71-89% was obtained. The limit of detection and precision of proposed method were 4.5 × 10-4 µg mL-1 and <4.11% (relative standard deviation), respectively. Based on the results from analysis of cefexime, in biological samples using the proposed method, the ability of this method to extract and pre-concentrate cefexime was confirmed. Also, satisfactory results from an in vitro study on drug release in simulated intestine media were obtained.


Asunto(s)
Cefixima/sangre , Cefixima/aislamiento & purificación , Nanopartículas de Magnetita/química , Cefixima/farmacocinética , Cefixima/orina , Cromatografía Líquida de Alta Presión , Humanos , Límite de Detección , Modelos Lineales , Polímeros/química , Reproducibilidad de los Resultados , Temperatura
3.
J Fluoresc ; 27(3): 921-927, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28078632

RESUMEN

Here a simple and sensitive fluorescent assay for detecting Cefixime based on inner filter effect (IFE) has been proven, which is conceptually different from the previously reported CEF fluorescent assays. In this sensing platform, fluorescent carbon dots (CDs) were prepared by one-pot synthesis and was directly used as fluorophore in IFE. The method is based on the complexation reaction between cefixime and palladium ion in the presence of acidic buffer solution (pH 4). The Pd(II)-CEFcomplex was capable of functioning as a powerful absorber in IFE to influence the excitation of fluorophore (CDs). Production Pd(II)-CEFcomplex induced the absorption band transition from 310 to 400 nm, which resulted in the complementary overlap with the excitation spectra of CDs. Due to the competitive absorption, the excitation of CDs was significantly weakened, resulting in the quenching of CDs. The present IFE-based sensing strategy showed a good linear relationship from 0.2 × 10-6 M to 8 × 10-6 M (R2 = 0.987) and provided an exciting detection limit of 0.5 × 10-7 (3δ/slope). The proposed method has been successfully applied for the determination of cefixime in raw milk and human urine samples.


Asunto(s)
Técnicas Biosensibles/métodos , Carbono/química , Cefixima/orina , Fluorescencia , Nanopartículas del Metal/química , Leche/química , Puntos Cuánticos/química , Animales , Antibacterianos/metabolismo , Antibacterianos/orina , Cefixima/metabolismo , Colorantes Fluorescentes/química , Humanos , Límite de Detección , Espectrometría de Fluorescencia
4.
Anal Biochem ; 407(1): 79-88, 2010 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-20678464

RESUMEN

Electroreduction and adsorption of cefixime was studied in phosphate buffer by cyclic voltammetry (CV), differential pulse cathodic adsorptive stripping voltammetry (DPCAdSV), and square-wave cathodic adsorptive stripping voltammetry (SWCAdSV) at hanging mercury drop electrode (HMDE). These fully validated sensitive and reproducible cathodic adsorptive stripping voltammetric procedures were applied for the trace determination of the bulk drug in pharmaceutical formulations and in human urine. The optimal experimental parameters were as follows: accumulation potential=-0.1 V (vs. Ag/AgCl, 3M KCl), accumulation time=50s, frequency=140 Hz, pulse amplitude=0.07 V, and scan increment=10 mV in phosphate buffer (pH 2.6). The first peak current showed a linear dependence with the drug concentration over the range of 50 ng ml(-1) to 25.6 µg ml(-1). The achieved limit of detection and limit of quantitation were 3.99 and 13.3 ng ml(-1) by SWCAdSV and 7.98 and 26.6 ng ml(-1) by DPCAdSV, respectively. The procedure was applied to assay the drug in tablets. Applicability was also tested in urine samples. Peak current was linear with the drug concentration in the range of 1 to 60 µg ml(-1) of the urine, and minimum detectability was found to be 12.6 ng ml(-1) by SWCAdSV and 58.4 ng ml(-1) by DPCAdSV.


Asunto(s)
Antibacterianos/análisis , Cefixima/análisis , Técnicas Electroquímicas/métodos , Adsorción , Antibacterianos/orina , Cefixima/orina , Electrodos , Humanos , Concentración de Iones de Hidrógeno , Reproducibilidad de los Resultados , Comprimidos
5.
J Pharm Biomed Anal ; 31(4): 811-8, 2003 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-12644208

RESUMEN

Electrochemical reduction behavior of cephalosporins, Cefixime (CF) and Cefpodoxime Proxetil (CP) have been studied by using different voltammetric techniques in Britton-Robinson buffer system. Two well defined cathodic waves are observed for both the compounds in the entire pH range. Number of electrons transferred in the reduction process was calculated and the reduction mechanism is proposed. The results indicate that the process of both the compounds is irreversible and diffusion-controlled. The peak currents for CF and CP are found to be linear over the range of concentration 6.0 x 10(-8) to 1.2 x 10(-5) mol l(-1) and 8.8 x 10(-8) to 1.1 x 10(-5) mol l(-1), respectively. The lower detection limits are found to be 4.6 x 10(-8) and 8.52 x 10(-8) mol l(-1) for the two compounds. A differential pulse voltammetric method has been developed for the determination of these drugs in pharmaceutical formulations and urine samples.


Asunto(s)
Cefixima/química , Cefixima/orina , Ceftizoxima/análogos & derivados , Ceftizoxima/química , Ceftizoxima/orina , Química Farmacéutica , Electroquímica , Preparaciones Farmacéuticas , Cefpodoxima Proxetilo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA